社交媒体数据用于妊娠期药物暴露与出生缺陷监测的可行性评估
本研究评估利用社交媒体数据作为妊娠期药物监测替代数据源的可行性。研究通过自动化方法识别196名报告婴儿出生缺陷的孕妇和196名未报告的孕妇,提取用药与出生缺陷信息。结果显示报告出生缺陷者中35%报告妊娠期用药(对照组17%),但出生缺陷报告率(0.44%)低于一般人群(3%),提示社交媒体数据尚不能替代妊娠登记系统。
要点
- 社交媒体可提取妊娠期用药与出生缺陷信息,但数据常不完整。
- 报告出生缺陷的孕妇中35%报告妊娠期用药,对照组为17%。
- 该队列出生缺陷报告率0.44%,低于一般人群3%,提示漏报。
核心结论
- Twitter数据可捕获妊娠期用药与出生缺陷信息,但尚不能替代妊娠登记系统。
研究设计与样本
- 通过自动化方法识别Twitter上孕妇账户,纳入196名报告婴儿出生缺陷的孕妇和196名未报告的孕妇,提取妊娠与人口学、用药及出生缺陷信息。
主要发现
- 报告出生缺陷的孕妇中35%报告妊娠期使用一种或多种药物,对照组为17%。
- 校正年龄、种族和居住地后,报告出生缺陷的孕妇用药率仍更高。
- 该妊娠队列出生缺陷报告率为0.44%,一般人群为3%。
临床怎么用
- 目前社交媒体数据不能替代妊娠登记系统用于监管决策。
- 改进自动提取与标注方法可能提升社交媒体数据对妊娠结局监管决策的价值。
局限性
- 社交媒体提取的信息常不完整。
- 出生缺陷报告率低于一般人群,提示存在漏报或选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Adverse effects of medications taken during pregnancy are traditionally studied through post-marketing pregnancy registries, which have limitations. Social media data may be an alternative data source for pregnancy surveillance studies. OBJECTIVE: The objective of this study was to assess the feasibility of using social media data as an alternative source for pregnancy surveillance for regulatory decision making. METHODS: We created an automated method to identify Twitter accounts of pregnant women. We identified 196 pregnant women with a mention of a birth defect in relation to their baby and 196 without a mention of a birth defect in relation to their baby. We extracted information on pregnancy and maternal demographics, medication intake and timing, and birth defects. RESULTS: Although often incomplete, we extracted data for the majority of the pregnancies. Among women that reported birth defects, 35% reported taking one or more medications during pregnancy compared with 17% of controls. After accounting for age, race, and place of residence, a higher medication intake was observed in women who reported birth defects. The rate of birth defects in the pregnancy cohort was lower (0.44%) compared with the rate in the general population (3%). CONCLUSIONS: Twitter data capture information on medication intake and birth defects; however, the information obtained cannot replace pregnancy registries at this time. Development of improved methods to automatically extract and annotate social media data may increase their value to support regulatory decision making regarding pregnancy outcomes in women using medications during their pregnancies.
引用
- Golder S, Chiuve S, Weissenbacher D, et al. Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy. Drug Saf. 2019. PMID: 30284214. doi:10.1007/s40264-018-0731-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。